Thursday April 25, 2019
Home India Indian Railwa...

Indian Railways adds 2 more Coaches to ‘Lifeline Express’ for Detection and Control of Oral, Breast and Cervical Cancer

Till date the 'Lifeline Express' has taken up projects at 177 places across India

:Pune Karjat passenger Indian Railways (representational Image), Wikimedia

New Delhi, Dec 8, 2016: The Indian Railways on Thursday added two more coaches to the ‘Lifeline Express’ for the detection and control of oral, breast and cervical cancer, officials said.

The two additional coaches were added during a ceremony held here which was attended by Railway Minister Suresh Prabhu and Union Health Minister J.P Nadda.

Nadda said that this initiative will help in reaching out to rural areas which have insufficient medical facilities, or areas hit by natural disasters.

NewsGram brings to you latest new stories in India.

“I thank Indian Railways for this approach as we have to provide health services wherever possible, especially in the inaccessible places where the train can go,” Nadda elaborated.

Earlier the ‘Lifeline Express’ had five coaches.

The ‘Lifeline Express’ which started its journey in 1991 has so far treated over one million disabled poor in rural India, all free of cost, made possible with the ‘donated’ services of over 200,000 medical professionals from around the world.

Look for latest news from India in NewsGram.

According to the railways, the ‘Lifeline Express’ will have three fully equipped operation theatres for free-of-cost services for the rural poor across India.

Till date the ‘Lifeline Express’ has taken up projects at 177 places across India.

It has performed more than one lakh surgeries for the restoration of mobility, vision, hearing and correction of facial deformities.

The ‘Lifeline Express’ is also popularly known as the ‘Magic Train of India’. (IANS)

Next Story

Risk of Cervical Cancer Highest in Middle-aged Indian Women

" While PAP test is much more likely to miss precancerous cervical disease, HPV testing is more sensitive for detecting localised infection and marginally less sensitive for distant infection," Das noted

Cancer Ribbon. Pixabay

Nearly 50 per cent of middle-aged women in India were found to have positive cases of high-risk human papillomavirus (HPV) — the main risk factor for cervical cancer, says a report from SRL Diagnostics.

Human papilloma virus (HPV) is a group of viruses that are extremely common worldwide. There are more than 100 types of HPV, of which at least 14 are cancer-causing (also known as high risk type).

The virus is mainly transmitted through sexual contact and most people are infected with HPV shortly after the onset of sexual activity.

Two HPV types (16 and 18) cause 70 per cent of cervical cancers and precancerous cervical lesions.

Analysis of HPV test reports of 4,500 women pan-India between 2014 and 2018, showed that women aged between 31 and 45 years had the highest percentage of high-risk HPV at 47 per cent.

This was followed by 30 per cent of women aged between 16 and 30 years being affected by the risk.

Cancer survivor, flickr

Cervical cancer accounts for one-third of all global deaths, with 74,000 deaths occurring annually and is the second leading cause of cancer deaths among women in India.

However, “cervical cancer is also the only cancer which is preventable if care is taken in the initial stage”, said B.R Das from SRL Diagnostics in a statement issued here on Saturday.

“The high mortality rate from cervical cancer globally could be reduced through a comprehensive approach that includes screening, early diagnosis and treatment programmes,” he added.

Also Read- Premature to Say Social Media Use Leads to Depression

Besides vaccination before girls become sexually active, secondary prevention can be done by regular cervical smear of PAP smear which can pick up any abnormal cells in the cervix before they become cancerous.

“While PAP test is much more likely to miss precancerous cervical disease, HPV testing is more sensitive for detecting localised infection and marginally less sensitive for distant infection,” Das noted. (IANS)